TY  - GEN
AU  - Popp,A W
AU  - Zysset,P K
AU  - Lippuner,K
TI  - Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics
SN  - 1433-2965
PY  - 2017///0110
KW  - Aromatase Inhibitors
KW  - adverse effects
KW  - Bone Density Conservation Agents
KW  - administration & dosage
KW  - Bone Diseases, Metabolic
KW  - chemically induced
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Denosumab
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Middle Aged
KW  - Osteoporotic Fractures
KW  - etiology
KW  - Spinal Fractures
KW  - Withholding Treatment
N1  - Publication Type: Case Reports; Journal Article
UR  - https://doi.org/10.1007/s00198-015-3458-6
ER  -